Press Releases

ENPICOM participates in Inno4vac, a European new public-private partnership to innovate vaccine development

The Innovative Medicines Initiative 2 (IMI2) Joint Undertaking mobilized more than €33 million to support Inno4vac, a pioneering public-private partnership to accelerate vaccine R&D timelines. Launched on 1st September 2021, it focuses on the design and application of new and highly advanced predictive models to allow a faster development and manufacturing of novel vaccines.

NanoImaging Services Collaborates with Viva Biotech to Offer an Integrated CryoEM Gene-to-Structure Workflow to Streamline Target Discovery

NanoImaging Services, Inc. and Viva Biotech Holdings have announced a partnership agreement to develop a streamlined, cryoEM enabled gene-to-structure workflow, to ultimately accelerate medicinal chemistry analysis.

Targeted reduction of SARS-COV-2 viral load in the nose with photodisinfection may reduce severity of lower tract respiratory disease

Reducing COVID-19 effects with Photodisinfection – Results presented at the IDWeek 2021 conference - a joint meeting of the Infectious Diseases Society of America (IDSA), Society for Healthcare Epidemiology of America (SHEA), the HIV Medical Association (HIVMA), the Pediatric Infectious Diseases Society (PIDS), and the Society of Infectious Diseases Pharmacists (SIDP).

Ciox Digital Direct expands clinical data accessibility for Payers

Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit

Curebase, Checkable Medical Announce Joint Clinical Trial to Assess Effectiveness of At-home Strep Test Kit

BOC Sciences Expands Amino Acid Synthesis Services to Promote Peptide Drug R&D

CD Formulation Unveils Hygroscopicity Evaluation for Drug Formulation

Creative Bioarray Launches Cell Immortalization Services to Extend Replicative Capacity of Target Cells and Accelerate Biomedical Research

DDA Platform Releases In Vitro Permeability Assay to Evaluate Drug Permeability and Predict Drug Absorption

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Verana Health Launches Population Health Data Engine to Accelerate Clinical Research, Advance Medical Care, and Improve Patient Outcomes

Creative Biogene Eatablished An Excellent Platform to Provide High Quality Virus-Like Particles

IntegrateRNA Launched Comprehensive LncRNA Pull-down Services: Supporting The Validation of LncRNA Biology

Calyx RIM Selected by Top 10 Global Pharmaceutical Company for Five-Year Agreement

Regulatory publishing solution selected based on reliability and innovation

BioIVT to Showcase Drug Discovery Research Advances Using Novel Hepatotoxicity Models

Researchers will discuss how they employed HEPATOPAC® and HEPATOMUNE® cultures in their disease modeling, lead selection, and ADME evaluation programs.

Certara’s Simcyp™ COVID-19 Vaccine Model Wins R&D 100 Award

Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services category

The MALDI-Imaging Lipidomics Service Is Now Available Through Lipidomics Platform

Profacgen Enables Custom Bioinformatics Software Development for Researchers Worldwide

CD ComputaBio Announces 3D-QSAR Service for Drug Design and Screening

CD ComputaBio, a reliable computational biology service provider located in New York, is always hammering at research and trials in order to provide customers with access to the latest software, technologies, and expertise at a competitive price and fast turnaround time. The company has recently launched 3D-QSAR services for scientists to accelerate the drug development process.

CluePoints Shortlisted for Multiple Awards in Recognition of Pioneering Risk-Based Quality Management Solution

CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality Management Software for clinical trials, has announced it has been shortlisted for three international awards. CluePoints, BioNTech and Pfizer’s Phase I/II/III study of SARS-COV-2 RNA vaccine BNT162b2 (Comirnaty) has been selected as a finalist for the Clinical Advance of the Year - COVID-19 Pandemic Special Recognition Award at the Scrip Awards. The company is also in the running for two Citeline Awards: ´Best Sponsor-facing Technology Initiative´ for their business intelligence platform, BEYOND. As well as ´Excellence in Innovation in Response to COVID-19 - Clinical Trial Activities´, for its work with Pfizer / BioNTech.

CD Formulation Offers Multiple Methods for Microbial Limit Test